164 related articles for article (PubMed ID: 33987436)
1. The neglected biliary mucus and its phosphatidylcholine content: a putative player in pathogenesis of primary cholangitis-a narrative review article.
Stremmel W; Lukasova M; Weiskirchen R
Ann Transl Med; 2021 Apr; 9(8):738. PubMed ID: 33987436
[TBL] [Abstract][Full Text] [Related]
2. Phosphatidylcholine Passes by Paracellular Transport to the Apical Side of the Polarized Biliary Tumor Cell Line Mz-ChA-1.
Stremmel W; Staffer S; Weiskirchen R
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31430850
[TBL] [Abstract][Full Text] [Related]
3. Phosphatidylcholine passes through lateral tight junctions for paracellular transport to the apical side of the polarized intestinal tumor cell-line CaCo2.
Stremmel W; Staffer S; Gan-Schreier H; Wannhoff A; Bach M; Gauss A
Biochim Biophys Acta; 2016 Sep; 1861(9 Pt A):1161-1169. PubMed ID: 27365309
[TBL] [Abstract][Full Text] [Related]
4. Genetic Mouse Models with Intestinal-Specific Tight Junction Deletion Resemble an Ulcerative Colitis Phenotype.
Stremmel W; Staffer S; Schneider MJ; Gan-Schreier H; Wannhoff A; Stuhrmann N; Gauss A; Wolburg H; Mahringer A; Swidsinski A; Efferth T
J Crohns Colitis; 2017 Oct; 11(10):1247-1257. PubMed ID: 28575164
[TBL] [Abstract][Full Text] [Related]
5. Biliary phosphatidylcholine and lysophosphatidylcholine profiles in sclerosing cholangitis.
Gauss A; Ehehalt R; Lehmann WD; Erben G; Weiss KH; Schaefer Y; Kloeters-Plachky P; Stiehl A; Stremmel W; Sauer P; Gotthardt DN
World J Gastroenterol; 2013 Sep; 19(33):5454-63. PubMed ID: 24023488
[TBL] [Abstract][Full Text] [Related]
6. Alterations in tight junctions differ between primary biliary cirrhosis and primary sclerosing cholangitis.
Sakisaka S; Kawaguchi T; Taniguchi E; Hanada S; Sasatomi K; Koga H; Harada M; Kimura R; Sata M; Sawada N; Mori M; Todo S; Kurohiji T
Hepatology; 2001 Jun; 33(6):1460-8. PubMed ID: 11391535
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor-alpha and interferon-gamma directly impair epithelial barrier function in cultured mouse cholangiocytes.
Hanada S; Harada M; Koga H; Kawaguchi T; Taniguchi E; Kumashiro R; Ueno T; Ueno Y; Ishii M; Sakisaka S; Sata M
Liver Int; 2003 Feb; 23(1):3-11. PubMed ID: 12640721
[TBL] [Abstract][Full Text] [Related]
8. Lysyl oxidase-like protein 2 (LOXL2) modulates barrier function in cholangiocytes in cholestasis.
Pollheimer MJ; Racedo S; Mikels-Vigdal A; Marshall D; Bowlus C; Lackner C; Madl T; Karlsen TH; Hov JR; Lyman SK; Adamkewicz J; Smith V; Moreau E; Zollner G; Eide TJ; Stojakovic T; Scharnagl H; Gruber HJ; Stauber RE; Trauner M; Fickert P
J Hepatol; 2018 Aug; 69(2):368-377. PubMed ID: 29709678
[TBL] [Abstract][Full Text] [Related]
9. Phosphatidylcholine and lysophosphatidylcholine in intestinal mucus of ulcerative colitis patients. A quantitative approach by nanoElectrospray-tandem mass spectrometry.
Ehehalt R; Wagenblast J; Erben G; Lehmann WD; Hinz U; Merle U; Stremmel W
Scand J Gastroenterol; 2004 Aug; 39(8):737-42. PubMed ID: 15513358
[TBL] [Abstract][Full Text] [Related]
10. Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma.
Chung BK; Karlsen TH; Folseraas T
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1390-1400. PubMed ID: 28844951
[TBL] [Abstract][Full Text] [Related]
11. Increased T-helper 2 cytokines in bile from patients with IgG4-related cholangitis disrupt the tight junction-associated biliary epithelial cell barrier.
Müller T; Beutler C; Picó AH; Otten M; Dürr A; Al-Abadi H; Guckelberger O; Meyer Zum Büschenfelde D; Jöhrens K; Volkmann M; Lankisch T; Voigtländer T; Anders M; Shibolet O; Jefferson DM; Podolsky DK; Fischer A; Veltzke-Schlieker W; Adler A; Baumgart DC; Sturm A; Wiedenmann B; Schott E; Berg T
Gastroenterology; 2013 May; 144(5):1116-28. PubMed ID: 23391819
[TBL] [Abstract][Full Text] [Related]
12. Increased prevalence of CFTR mutations and variants and decreased chloride secretion in primary sclerosing cholangitis.
Sheth S; Shea JC; Bishop MD; Chopra S; Regan MM; Malmberg E; Walker C; Ricci R; Tsui LC; Durie PR; Zielenski J; Freedman SD
Hum Genet; 2003 Aug; 113(3):286-92. PubMed ID: 12783301
[TBL] [Abstract][Full Text] [Related]
13. Phosphatidylcholine (lecithin) and the mucus layer: Evidence of therapeutic efficacy in ulcerative colitis?
Stremmel W; Hanemann A; Ehehalt R; Karner M; Braun A
Dig Dis; 2010; 28(3):490-6. PubMed ID: 20926877
[TBL] [Abstract][Full Text] [Related]
14. [Mucosal protection by phosphatidylcholine as new therapeutic concept in ulcerative colitis].
Stremmel W
Z Gastroenterol; 2013 Apr; 51(4):384-9. PubMed ID: 23585269
[TBL] [Abstract][Full Text] [Related]
15. Biliary tract instillation of a SMAC mimetic induces TRAIL-dependent acute sclerosing cholangitis-like injury in mice.
Guicciardi ME; Krishnan A; Bronk SF; Hirsova P; Griffith TS; Gores GJ
Cell Death Dis; 2017 Jan; 8(1):e2535. PubMed ID: 28055006
[TBL] [Abstract][Full Text] [Related]
16. Lack of association of common cystic fibrosis transmembrane conductance regulator gene mutations with primary sclerosing cholangitis.
Gallegos-Orozco JF; E Yurk C; Wang N; Rakela J; Charlton MR; Cutting GR; Balan V
Am J Gastroenterol; 2005 Apr; 100(4):874-8. PubMed ID: 15784035
[TBL] [Abstract][Full Text] [Related]
17. Animal models for primary sclerosing cholangitis.
Vierling JM
Best Pract Res Clin Gastroenterol; 2001 Aug; 15(4):591-610. PubMed ID: 11492970
[TBL] [Abstract][Full Text] [Related]
18. Exogenous phosphatidylcholine supplementation improves intestinal barrier defense against Clostridium difficile toxin.
Olson A; Diebel LN; Liberati DM
J Trauma Acute Care Surg; 2014 Oct; 77(4):570-5; discussion 576. PubMed ID: 25250596
[TBL] [Abstract][Full Text] [Related]
19. A biliary HCO3- umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes.
Hohenester S; Wenniger LM; Paulusma CC; van Vliet SJ; Jefferson DM; Elferink RP; Beuers U
Hepatology; 2012 Jan; 55(1):173-83. PubMed ID: 21932391
[TBL] [Abstract][Full Text] [Related]
20. What is the association of primary sclerosing cholangitis with sex and inflammatory bowel disease in Turkish patients?
Bayraktar Y; Arslan S; Saglam F; Uzunalimoglu B; Kayhan B
Hepatogastroenterology; 1998; 45(24):2064-72. PubMed ID: 9951867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
